Showing results (1-10 of 19,476) with videos related to
Sort By:
Pageof 1,948
Vascular Health and Risk Management|March 21, 2014
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and riskSylvia Haas, Christoph Bode, Bo Norrving, et al.Thrombosis and Haemostasis|September 28, 2012
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitorAlexander G G Turpie, Reinhold Kreutz, Juan Llau, et al.Journal of Thrombosis and Thrombolysis|January 1, 1996
New Therapeutic Opportunities for Heparins: What Does Low Molecular Weight Heparin Offer?TurpieClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2015
Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical PracticeMichael R Lassen, Sylvia Haas, Reinhold Kreutz, et al.Thrombosis Journal|August 6, 2014
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosisWalter Ageno, Lorenzo G Mantovani, Sylvia Haas, et al.The American Journal of Cardiology|February 24, 2001
Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trialA G TurpieActa Chirurgica Scandinavica. Supplementum|January 1, 1990
Enoxaparin prophylaxis in elective hip surgeryA G TurpieThe American Journal of Cardiology|September 20, 1997
New frontiers in the management of unstable coronary artery diseaseA G TurpieBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 24, 1999
Customizing our approach in deep vein thrombosis and pulmonary embolism treatment: overview of our clinical experienceA G TurpieOrthopedics|February 1, 1997
Low-molecular-weight heparin: from the bench to the orthopedic patientA G TurpiePageof 1,948